OM:ESSITY B
OM:ESSITY BHousehold Products

Does Essity's (OM:ESSITY B) Data Push and Share Buyback Signal a Digital Edge or Capital Priorities?

In recent days, Essity announced the continuation of its SEK 3 billion share buyback program and entered a new partnership with NielsenIQ to serve as its primary provider for point-of-sale and consumer intelligence solutions across the United States. This move towards recurring share repurchases and enhanced data-driven decision-making highlights Essity's commitment to strengthening shareholder value and accelerating digital transformation in key markets. We'll look at how Essity's data...
OM:CAMX
OM:CAMXPharmaceuticals

How Investors Are Reacting To Camurus (OM:CAMX) Monthly Semaglutide Data Showing Promising Obesity Results

Earlier this month, Camurus announced positive topline results from a Phase 1b trial evaluating CAM2056, its monthly FluidCrystal® semaglutide formulation, which demonstrated significant dose-dependent reductions in body weight, hemoglobin A1c, and fasting glucose in people with overweight or obesity, with efficacy comparable to or greater than weekly semaglutide. This study suggests CAM2056 could offer similar or stronger metabolic benefits with the convenience of monthly dosing,...
OM:SKF B
OM:SKF BMachinery

Should SKF’s COP30 Recognition for Remanufacturing Innovations Influence Action From AB SKF (OM:SKF B) Investors?

Earlier this month, AB SKF showcased its scalable clean technologies and circular solutions at COP30, receiving recognition for its remanufacturing initiatives as a winner of the Sustainable Business COP's Best Cases award. This award highlights SKF's advancement in industrial decarbonization, where innovative remanufacturing and oil regeneration technologies are reducing emissions and extending product lifecycles in heavy industry. We'll explore how the spotlight on SKF's award-winning...
OM:BIOA B
OM:BIOA BBiotechs

How New Lecanemab Data Releases at CTAD 2023 Could Shape BioArctic's (OM:BIOA B) Investment Case

BioArctic's partner Eisai recently announced the upcoming presentation of extensive new lecanemab (Leqembi) clinical and real-world data at the Clinical Trials on Alzheimer's Disease (CTAD) conference in San Diego from December 1-4, covering long-term treatment outcomes, subcutaneous administration, and real-world registry findings. These disclosures are expected to provide important insights into the long-term effectiveness, patient experience, and potential healthcare resource savings of...
OM:SAAB B
OM:SAAB BAerospace & Defense

Why Saab (OM:SAAB B) Is Down 6.2% After Securing Major Global Defense Contracts and Partnerships

In the past week, Saab AB announced several major defense contracts, including a €3.1 billion order for 17 Gripen E/F fighters from the Colombian Government, additional electronic warfare sensor suite orders from Airbus Defence and Space totaling approximately €549 million, and a SEK 510 million contract for Carl-Gustaf M4 deliveries to Denmark, alongside a new partnership with Ericsson Canada and Calian focused on advanced secure communications for Canadian defense. These developments...
OM:SKA B
OM:SKA BConstruction

A Closer Look at Skanska (OM:SKA B) Valuation Following New Contracts and Strong Q3 Performance

Skanska (OM:SKA B) has been making headlines after landing major new contracts in Finland and the US. The company also reported a solid third quarter, marked by rising net income and continued sales growth. See our latest analysis for Skanska. Between headline-grabbing contract wins in Finland and the US and a robust earnings report, Skanska has caught the market’s eye, as reflected in its 1.9% year-to-date share price return and a 14.8% total shareholder return over the past year. While...
OM:ALFA
OM:ALFAMachinery

Alfa Laval (OM:ALFA) Expands EDF Partnership: A Fresh Look at Valuation After Nuclear Energy Deal

Alfa Laval (OM:ALFA) has expanded its long-running partnership with Electricite de France (EDF), aiming to support the latest wave of nuclear energy projects in France. Their new agreement centers on advanced heat exchanger technology and a streamlined, modular approach for upcoming EPR2 reactors. See our latest analysis for Alfa Laval. Alfa Laval’s renewed focus on advanced nuclear energy solutions comes as momentum in its share price has recently faded, with a 7.9% decline year-to-date and...
OM:EMBRAC B
OM:EMBRAC BEntertainment

Embracer Group (OM:EMBRAC B) Valuation Check After Second Quarter Earnings Show Narrowed Losses

Embracer Group (OM:EMBRAC B) has just published its second quarter results, revealing a drop in sales and revenue compared to last year. However, the company managed to dramatically reduce its net loss year on year. See our latest analysis for Embracer Group. Embracer Group’s earnings release follows a challenging stretch for the shares, which have seen a sharp drop recently but a small recovery in the last 90 days. While the latest results show operational improvement, the 1-year total...
OM:EPRO B
OM:EPRO BMachinery

Electrolux Professional (OM:EPRO B): Evaluating Valuation Following Strategic Partnerships and New Sustainability Initiatives

Electrolux Professional (OM:EPRO B) recently rolled out a series of strategic moves, including teaming up with Mimbly on water-efficient technologies, shifting cooking production to Italy, and releasing new sustainability-focused product lines. See our latest analysis for Electrolux Professional. The recent pace of Electrolux Professional’s innovation and operational changes seems to have drawn mixed reactions from the market. The share price has given back 6% over the past month, even as the...
OM:ESSITY B
OM:ESSITY BHousehold Products

Essity (OM:ESSITY B): Exploring the Valuation Behind Recent Share Stability and Analyst Price Targets

Essity (OM:ESSITY B) shares have edged up slightly over the past month, adding a bit more than 0.1%. Investors watching the Swedish hygiene and health company can note this modest uptick as broader market dynamics and sector shifts continue to play out. See our latest analysis for Essity. The share price recently slipped lower year-to-date but has started to show some stability. Although the 1-year total shareholder return sits at -9.3%, those who held on for the past three or five years have...
OM:SAVE
OM:SAVECapital Markets

How Investors Are Reacting To Nordnet (OM:SAVE) Surpassing 2.3 Million Customers Amid Strong October Results

Nordnet AB (publ) reported that in October 2025, customers made 6,545,900 trades, net savings totaled SEK 7.7 billion, and the total savings capital reached SEK 1,176 billion. A key insight is the company's annual customer growth rate of 12.9%, bringing its customer base to over 2.31 million by the end of October. Given Nordnet's recent robust customer growth, we will examine how this positive momentum impacts the company's investment narrative and outlook. These 13 companies survived and...
OM:EPEN
OM:EPENElectronic

3 European Stocks Estimated To Be Up To 42.9% Below Intrinsic Value

The European stock market has experienced a positive upswing, with the pan-European STOXX Europe 600 Index rising by 1.77% as investors welcomed the reopening of the U.S. federal government, although enthusiasm was tempered by cooling sentiment around artificial intelligence investments. Against this backdrop, identifying undervalued stocks becomes crucial for investors looking to capitalize on potential opportunities, particularly in an environment where economic indicators and investor...